載入...
Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
Marginal zone lymphomas (MZLs) consist of a diverse family of malignancies, which are derived from B-cells. The disease subtypes are recognized extranodal, nodal, and splenic MZLs. The disease characteristics, clinical course, and treatment vary considerably based on the site of involvement. In 2017...
Na minha lista:
| 發表在: | Cancer Manag Res |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5877869/ https://ncbi.nlm.nih.gov/pubmed/29628774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S133291 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|